Cargando…

Yinchen Linggui Zhugan decoction ameliorates high fat diet-induced nonalcoholic fatty liver disease by modulation of SIRT1/Nrf2 signaling pathway and gut microbiota

Yinchen Linggui Zhugan decoction (YLZD) is an effective and classical traditional herbal prescription for treating the nonalcoholic fatty liver disease (NAFLD) and has been proven to be effective in the regulation of lipid metabolism disorder and attenuate inflammation for a NAFLD rat model. However...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Hui, Mao, Tangyou, Sun, Zhongmei, Shi, Lei, Han, Xiao, Zhang, Yang, Zhang, Xiaosi, Wang, Jiali, Hu, Juncong, Zhang, Liming, Li, Junxiang, Han, Haixiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791106/ https://www.ncbi.nlm.nih.gov/pubmed/36578580 http://dx.doi.org/10.3389/fmicb.2022.1001778

Ejemplares similares

Protective Effects and Mechanisms of Yinchen Linggui Zhugan Decoction in HFD-Induced Nonalcoholic Fatty Liver Disease Rats Based on Network Pharmacology and Experimental Verification
por: Jiang, Hui, et al.
Publicado: (2022)

Yinchen Linggui Zhugan Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats by Regulating the Nrf2/ARE Signaling Pathway
por: Guo, Yi, et al.
Publicado: (2017)

Linggui Zhugan Decoction for peripheral vertigo: A protocol for systematic review and meta-analysis
por: Ma, Hongmei, et al.
Publicado: (2021)

Modified Linggui Zhugan Decoction protects against ventricular remodeling through ameliorating mitochondrial damage in post-myocardial infarction rats
por: Xiang, Mi, et al.
Publicado: (2023)

A preparation technology of volatile components in Linggui Zhugan decoction based on the transfer of cinnamaldehyde and its anti-gastric ulcer effect
por: Li, Ling, et al.
Publicado: (2023)

Efficacy and safety of Linggui Zhugan decoction in the treatment of chronic heart failure with Yang deficiency: A protocol for systematic review and meta-analysis
por: Li, Yumeng, et al.
Publicado: (2021)

Effectiveness and safety of Linggui Zhugan decoction for the treatment of premature contraction in patients with coronary heart disease: A systematic review and meta-analysis
por: Liu, Longkun, et al.
Publicado: (2022)

Linggui Zhugan Decoction activates the SIRT1-AMPK-PGC1α signaling pathway to improve mitochondrial and oxidative damage in rats with chronic heart failure caused by myocardial infarction
por: Yu, Siyi, et al.
Publicado: (2023)

Linggui Zhugan Formula Improves Glucose and Lipid Levels and Alters Gut Microbiota in High-Fat Diet-Induced Diabetic Mice
por: Wu, Rui, et al.
Publicado: (2019)

An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway
por: Xie, Tian-hong, et al.
Publicado: (2017)

Retracted: An ErChen and YinChen Decoction Ameliorates High-Fat-Induced Nonalcoholic Steatohepatitis in Rats by Regulating JNK1 Signaling Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2019)

Protective Effect of Qingchang Wenzhong Decoction on Colitis and Colitis-Related Carcinogenesis by Regulating Inflammation and Intestinal Fibrosis
por: Cheng, Yuan, et al.
Publicado: (2023)

Quantitative Analysis of Six Phenolic Acids in Artemisia capillaris (Yinchen) by HPLC-DAD and Their Transformation Pathways in Decoction Preparation Process
por: Tian, Fang, et al.
Publicado: (2020)

Linggui Qihua Decoction Inhibits Atrial Fibrosis by Regulating TGF-β1/Smad2/3 Signal Pathway
por: Xiong, Shuang, et al.
Publicado: (2023)

Herbal Medicine Hewei Jiangni Decoction Is Noninferior to Oral Omeprazole for the Treatment of Nonerosive Gastroesophageal Reflux Disease: A Randomized, Double-Blind, and Double-Dummy Controlled Trail
por: Li, Feng, et al.
Publicado: (2022)

Network Pharmacology Identifies the Mechanisms of Action of Tongxie Anchang Decoction in the Treatment of Irritable Bowel Syndrome with Diarrhea Predominant
por: Tan, Xiang, et al.
Publicado: (2020)

Efficacy and safety of Yinchen Sini decoction in treating biliary atresia patients after Kasai portoenterostomy: A systematic review and meta-analysis protocol
por: Chen, Guoming, et al.
Publicado: (2019)

Tongxie Anchang Decoction Relieves Visceral Hypersensitivity in Diarrhea-Predominant Irritable Bowel Syndrome Rats by Regulating the NGF/TrkA Signaling Pathway
por: Tan, Xiang, et al.
Publicado: (2021)

Effect of Different Ratios of Yinchen and Gancao Decoction on ANIT-Treated Cholestatic Liver Injury in Mice and Its Potential Underlying Mechanism
por: Su, Huizong, et al.
Publicado: (2021)

Integrated network analysis and metabolomics reveal the molecular mechanism of Yinchen Sini decoction in CCl(4)-induced acute liver injury
por: Zheng, Weiwei, et al.
Publicado: (2023)

Long-term trends in the burden of inflammatory bowel disease in China over three decades: A joinpoint regression and age-period-cohort analysis based on GBD 2019
por: Zhang, Yang, et al.
Publicado: (2022)

Qingchang Wenzhong Decoction Alleviates DSS-Induced Inflammatory Bowel Disease by Inhibiting M1 Macrophage Polarization In Vitro and In Vivo
por: Lu, Qiongqiong, et al.
Publicado: (2022)

Effectiveness and safety of Injinoryung-San-Gagambang (Yinchen Wuling powder) decoction on stroke patients with elevated serum liver enzymes: Three case reports
por: Chu, Hongmin, et al.
Publicado: (2018)

The role of Akkermansia muciniphila in inflammatory bowel disease: Current knowledge and perspectives
por: Zheng, Mengyu, et al.
Publicado: (2023)

Gut Microbiota-Mediated NLRP12 Expression Drives the Attenuation of Dextran Sulphate Sodium-Induced Ulcerative Colitis by Qingchang Wenzhong Decoction
por: Sun, Zhongmei, et al.
Publicado: (2019)

An Integrative Analysis Reveals the Potential Mechanism between Herbal Medicine Yinchen and Immunoregulation in Hepatocellular Carcinoma
por: Mo, Zhuomao, et al.
Publicado: (2020)

Qingchang Wenzhong Decoction Accelerates Intestinal Mucosal Healing Through Modulation of Dysregulated Gut Microbiome, Intestinal Barrier and Immune Responses in Mice
por: Sun, Zhongmei, et al.
Publicado: (2021)

How to improve the diagnosis of neoplastic transformation of gastric hyperplastic polyps in the context of autoimmune gastritis?: A case report and lierature review
por: Xing, Yunqi, et al.
Publicado: (2022)

Huangqin decoction alleviates lipid metabolism disorders and insulin resistance in nonalcoholic fatty liver disease by triggering Sirt1/NF-κB pathway
por: Yan, Bao-Fei, et al.
Publicado: (2023)

Effects and Mechanism of Oxymatrine Combined with Compound Yinchen Granules on the Apoptosis of Hepatocytes through the Akt/FoxO3a/Bim Pathway
por: Zhang, Xian, et al.
Publicado: (2022)

Inflammatory bowel disease and risk of idiopathic pulmonary fibrosis: A protocol for systematic review and meta-analysis
por: Wang, Jiali, et al.
Publicado: (2022)

LB100 ameliorates nonalcoholic fatty liver disease via the AMPK/Sirt1 pathway
por: Chen, Xue-Yang, et al.
Publicado: (2019)

Qingchang Wenzhong Decoction Attenuates DSS-Induced Colitis in Rats by Reducing Inflammation and Improving Intestinal Barrier Function via Upregulating the MSP/RON Signalling Pathway
por: Mao, Tangyou, et al.
Publicado: (2017)

Identification of Molecular Targets and Potential Mechanisms of Yinchen Wuling San Against Head and Neck Squamous Cell Carcinoma by Network Pharmacology and Molecular Docking
por: Zhang, Biyu, et al.
Publicado: (2022)

Attenuating effects of allantoin on oxidative stress in a mouse model of nonalcoholic steatohepatitis: role of SIRT1/Nrf2 pathway
por: Hamidi-zad, Zeinab, et al.
Publicado: (2021)

Stachydrine ameliorates hypoxia reoxygenation injury of cardiomyocyte via enhancing SIRT1-Nrf2 pathway
por: Zhu, Xi, et al.
Publicado: (2023)

Evaluation of the Mechanism of Modified Lingguizhugan Decoction in the Treatment of Nonalcoholic Fatty Liver Disease
por: Yang, Fuyuan, et al.
Publicado: (2022)

Gegen Qinlian Decoction Ameliorates Nonalcoholic Fatty Liver Disease in Rats via Oxidative Stress, Inflammation, and the NLRP3 Signal Axis
por: Ying, Yuqi, et al.
Publicado: (2021)

SIRT1 Activator E1231 Alleviates Nonalcoholic Fatty Liver Disease by Regulating Lipid Metabolism
por: Han, Jiangxue, et al.
Publicado: (2023)

Comprehensive Analysis of Fecal Microbiome and Metabolomics in Hepatic Fibrosis Rats Reveal Hepatoprotective Effects of Yinchen Wuling Powder From the Host-Microbial Metabolic Axis
por: Zhang, Yumeng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dcj845n009un0bpotni382r9si